Cardium Therapeutics Salary

Cardium Therapeutics average salary is $-, median salary is $- with a salary range from $- to $-.
Cardium Therapeutics salaries are collected from government agencies and companies. Each salary is associated with a real job position. Cardium Therapeutics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.

Low: -

Average: -

Median: -

High: -

Cardium Therapeutics Jobs

Job Title

Salaries

City

Year

More Info

Cardium Therapeutics Jobs

Today’s New Jobs Immediate job opening
Only $100K+ Jobs Require free registration. Manager, Director, VP, C-level Jobs

Calculate how much you could earn

It's FREE. Based on your input and our analysis. How we do it?

All fields are required for calculation accuracy.

Employer
Job Title
City
Experience
Email
We will send you an email to access your personalized report.
We won’t share your email address

Recent Cardium Therapeutics Salaries (May 22, 2012)

Biostatistician	Macrogenics	$75,050	Rockville, MD, 20847	09/14/2010
Analyst	The Ogilvy Group Inc. - Ogilvy & Mather	$60,000	New York, NY, 10001	09/14/2010

Cardium Therapeutics salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List

8.5 million company & government reported salaries with date & location
Salary calculator rank & calculate your salary
151 million W-2s pay scale statistics in U.S.

Related Cardium Therapeutics Salary

Cardium Therapeutics Information

Cardium Therapeutics Inc
Industry: Medical Equipment
City: San Diego, CA
Cardium Therapeutics Inc. and its parent Aries Ventures, Inc. (theCompany), headquartered in San Diego, are primarily focused on interventionalcardiology and the development and commercialization of non-surgicalcardiovascular gene therapeutics. The Company's lead product candidate,Generx(TM), is a non-surgical angiogenic therapy designed to be a one-timetreatment for patients with recurrent angina due to coronary artery disease.Generx and the related cardiovascular technology platform were pioneered byCollateral Therapeutics, a San Diego-based biotechnology company co-founded byCardium's C...
Cardium Therapeutics Inc Profile
Christopher Reinhard